CC
ZEPP

Centiva Capital’s Zepp Health ZEPP Stock Holding History

Centiva Capital’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,757
Closed -$538K – 1641
2025
Q3 		$538K Buy
+11,757
New +$356K 0.01% 618

Other funds holding ZEPP

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
MM
Monolith Management Hong Kong $332M AUM 119.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Centiva Capital's ZEPP Position: Q4 2025 in Review

Centiva Capital sold out of Zepp Health (ZEPP) in Q4 2025, closing a stake of 11,757 shares — an estimated $538K sold.

Centiva Capital first reported a position in ZEPP in Q3 2025 and held it in 1 quarter. The position peaked at $538K in Q3 2025. 38 funds tracked by Wall St. Rank hold ZEPP as of Q4 2025.

  • Centiva Capital reported no remaining Zepp Health position as of Q4 2025 after selling out during the quarter.
  • Centiva Capital sold 11,757 Zepp Health shares in Q4 2025, an estimated $538K.
  • Centiva Capital first reported a position in Zepp Health in Q3 2025 and held it in 1 quarter.
  • Centiva Capital's Zepp Health position peaked at $538K in Q3 2025.
  • 38 funds tracked by Wall St. Rank held Zepp Health as of Q4 2025.

Based on Centiva Capital's 13F filing for Q4 2025, filed 13 Feb 2026.